Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-085051
Filing Date
2011-03-31
Accepted
2011-03-31 17:08:30
Documents
17
Period of Report
2010-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1085039
2 EXCLUSIVE SUBLICENSE AGREEMENT dex1048.htm EX-10.48 68470
3 SPONSORED RESEARCH AND VACCINE PRODUCTION AGREEMENT dex1049.htm EX-10.49 71554
4 PLACEMENT AGENT AGREEMENT - GILFORD dex1050.htm EX-10.50 24709
5 PLACEMENT AGENT AGREEMENT - SCARSDALE dex1051.htm EX-10.51 37365
6 CONSULTING AGREEMENT dex1052.htm EX-10.52 114908
7 ADVISORY SERVICES AGREEMENT dex1053.htm EX-10.53 25124
8 CO-PLACEMENT AGENTS AGREEMENT dex1054.htm EX-10.54 46656
9 CONSENT OF MARCUM LLP dex231.htm EX-23.1 1683
10 CONSENT OF STONEFIELD JOSEPHSON, INC. dex232.htm EX-23.2 1706
11 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 10869
12 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 10857
13 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex321.htm EX-32.1 4204
14 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex322.htm EX-32.2 4189
15 GRAPHIC g168660ex50.jpg GRAPHIC 11994
16 GRAPHIC g168660ex51.jpg GRAPHIC 5287
17 GRAPHIC g168660ex54.jpg GRAPHIC 6600
  Complete submission text file 0001193125-11-085051.txt   1542018
Mailing Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367
Business Address 21900 BURBANK BLVD. 3RD FLOOR WOODLAND HILLS CA 91367 818-992-2907
ImmunoCellular Therapeutics, Ltd. (Filer) CIK: 0000822411 (see all company filings)

EIN.: 931301885 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 033-17264-NY | Film No.: 11727376
SIC: 2834 Pharmaceutical Preparations